Ogkologos

4396 POSTS 0 COMMENTS

FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection

Ogkologos - October 2, 2025

Study presents an AI-guided approach to target cancer antigens

Ogkologos - October 1, 2025

Efficacy of ICI Combined with Chemotherapy in Patients with Advanced Penile...

Ogkologos - October 1, 2025

Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected...

Ogkologos - September 30, 2025

HER2 Is Not a Predictive Biomarker of Benefit From Up-front Chemotherapy...

Ogkologos - September 29, 2025

EMA Recommends Granting a Marketing Authorisation for Elinzanetant

Ogkologos - September 26, 2025

ESMO Calls on EU Research Ministers to Prioritise Cancer Research Funding...

Ogkologos - September 25, 2025

AI is impacting cancer care, but also the environment

Ogkologos - September 25, 2025

FDA Approves Selumetinib for Paediatric Patients 1 Year of Age and...

Ogkologos - September 25, 2025

Weekly Cisplatin-Based Chemoradiotherapy Improves RFS and OS, Although Not Statistically Significant,...

Ogkologos - September 24, 2025

1...373839...440 Page 38 of 440

MOST POPULAR

EMA Recommends Extension of Indications for Tislelizumab

July 24, 2025

Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast...

December 13, 2019

Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment...

March 12, 2026

ESMO’s Expert Consensus: Do Not Discontinue or Delay Cancer Treatment That...

July 31, 2020

FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection

Study presents an AI-guided approach to target cancer antigens

Efficacy of ICI Combined with Chemotherapy in Patients with Advanced Penile...

Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected...

HER2 Is Not a Predictive Biomarker of Benefit From Up-front Chemotherapy...

EMA Recommends Granting a Marketing Authorisation for Elinzanetant

ESMO Calls on EU Research Ministers to Prioritise Cancer Research Funding...

AI is impacting cancer care, but also the environment

FDA Approves Selumetinib for Paediatric Patients 1 Year of Age and...

Weekly Cisplatin-Based Chemoradiotherapy Improves RFS and OS, Although Not Statistically Significant,...

MOST POPULAR

EMA Recommends Extension of Indications for Tislelizumab

Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast...

Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment...

ESMO’s Expert Consensus: Do Not Discontinue or Delay Cancer Treatment That...

HOT NEWS

Delivering the future of paediatric brain tumour therapy

Mom Walks In To Comfort Scared Son After Surgery And Sees...

EMA Recommends Approval of the Marketing Authorisation for Tagraxofusp

FDA Approves Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma

POPULAR POSTS

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

POPULAR CATEGORY